although
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
identifi
caus
agent
sar
pathogen
includ
human
metapneumoviru
chlamydia
pneumonia
detect
togeth
sarscov
patient
moreov
patient
sar
diarrhea
howev
case
sarscov
could
isol
stool
patient
outbreak
sar
patient
definit
identifi
pathogen
inform
date
suggest
sarscov
necessari
suffici
causat
sar
human
remain
determin
whether
microbi
cofactor
enhanc
sever
transmiss
diseas
examin
electron
microscopi
cell
cultur
taken
throat
swab
woman
sar
case
surpris
presenc
viruslik
particl
apart
sarscov
small
round
particl
nm
diamet
differ
greatli
coronaviru
viral
rna
extract
cell
cultur
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
revers
transcript
perform
use
superscript
iii
revers
transcriptas
invitrogen
carlsbad
ca
usa
aliquot
cdna
amplifi
platinum
taq
dna
polymeras
high
fidel
invitrogen
random
primer
sequenc
analysi
bp
indic
isol
high
sequenc
ident
polioviru
sabin
confirm
result
gain
detail
isol
name
isol
viru
throat
swab
use
human
rhabdomyosarcoma
rd
cell
line
design
primer
target
region
nt
forward
primer
revers
primer
sabin
strain
genbank
access
number
perform
anoth
polymeras
chain
reaction
pcr
assay
pcr
product
clone
pgetm
vector
promega
madison
wi
usa
sequenc
sequenc
compar
genbank
use
basic
local
align
search
tool
blast
http
blastncbinlmnih
govblastcgi
show
homolog
sabin
isol
neutral
assay
perform
accord
world
health
organ
manual
virolog
investig
polio
set
polyclon
antiserum
pool
rivm
gift
chines
center
diseas
control
prevent
cdc
isol
neutral
antiserum
pool
polioviru
type
indic
viru
ident
polioviru
type
find
indirect
immunofluoresc
assay
confirm
result
fig
investig
whether
polioviru
type
present
sar
patient
collect
viru
isol
andor
revers
transcript
rt
pcr
specimen
subject
male
seven
femal
mean
age
year
rang
year
admit
beij
hospit
march
june
fulfil
case
definit
sar
seven
postmortem
tissu
sampl
man
sar
case
stool
specimen
healthi
individu
patient
hepat
hepat
b
ten
postmortem
tissu
sampl
five
patient
hepat
b
avail
control
tabl
viral
rna
extract
rtpcr
carri
use
primer
target
region
nucleasefre
water
use
neg
control
pcr
procedur
perform
twice
result
show
includ
case
five
saliva
specimen
three
eight
sputum
specimen
five
seven
urin
specimen
five
throat
swab
six
stool
specimen
sar
patient
posit
opvlik
polioviru
confirm
sar
patient
harbor
opvlik
polioviru
tabl
contrast
sar
specimen
one
stool
specimen
control
subject
child
hepat
posit
opvlik
polioviru
find
significantli
differ
sar
patient
p
interestingli
among
seven
postmortem
tissu
sampl
man
kidney
small
intestin
brain
lung
liver
spleen
pancrea
posit
opvlik
polioviru
neg
result
postmortem
kidney
small
intestin
tissu
sampl
five
patient
hepat
b
addit
three
doubli
infect
patient
sarscov
opvlik
polioviru
die
case
gave
mortal
six
sar
patient
without
opvlik
polioviru
infect
still
aliv
worth
mention
three
deceas
subject
older
year
age
indic
never
receiv
vaccin
opvlik
polioviru
vaccin
china
initi
poliomyel
prevail
sever
decad
great
progress
made
sinc
toward
erad
opv
effect
vaccin
polioviru
infect
mutat
deriv
detect
fig
indirect
immunofluoresc
assay
viru
isol
cell
without
viru
inocul
neg
green
fluoresc
b
cell
inocul
viru
isol
show
high
intens
green
fluoresc
cytoplasm
suggest
polioviru
type
replic
cultur
cell
normal
popul
week
month
immun
mainli
among
children
surprisingli
detect
opvlik
polioviru
mani
adult
sar
patient
polioviru
transmit
person
person
close
contact
either
upper
respiratori
tract
secret
fecalor
rout
similarli
sarscov
could
enabl
coinfect
polioviru
sarscov
reduc
immun
polioviru
type
adult
impair
immun
sar
patient
also
made
opvlik
polioviru
infect
possibl
agreement
previou
report
postmortem
result
show
widespread
hemorrhag
necrosi
spleen
lymph
node
decreas
number
inher
lymphocyt
data
shown
suggest
sar
patient
sever
immunocompromis
moreov
lymphopenia
steroid
treatment
includ
cohort
data
shown
caus
deterior
immunolog
function
patient
sar
factor
may
facilit
spread
replic
opvlik
polioviru
howev
still
unknown
whether
one
viru
infect
virus
infect
simultan
highli
improb
result
fals
follow
none
stool
sampl
healthi
control
one
hepatitisvirusinfect
control
child
may
inocul
opv
sever
month
previous
posit
opvlik
polioviru
howev
stool
sampl
sar
patient
posit
opvlik
polioviru
control
neg
laboratori
use
studi
previous
use
polioviru
research
limit
chanc
contamin
viru
isol
result
confirm
anoth
laboratori
pcr
amplif
posit
neg
result
opvlik
polioviru
repeat
result
addit
neutral
antibodi
titer
sabin
isol
case
serum
versu
serum
collect
patient
day
later
data
shown
support
find
opvlik
polioviru
infect
sar
patient
result
obtain
studi
indic
exist
opvlik
polioviru
adult
case
sar
howev
exact
relationship
opvlik
polioviru
throat
swab
case
use
viru
isol
revers
transcript
polymeras
chain
reaction
rtpcr
assay
specimen
control
sampl
directli
subject
rtpcr
posit
neg
nd
detect
rtpcr
perform
directli
postmortem
tissu
specimen
case
posit
result
kidney
small
intestin
neg
result
brain
lung
liver
spleen
pancrea
postmortem
tissu
control
opvlik
polioviru
type
detect
